)

Biocon (BIOCON) investor relations material
Biocon Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Q1 FY26 saw 15% year-over-year operating revenue growth, led by biosimilars, CRDMO, and generics segments.
Completed a ₹4,500 crore QIP, the first equity raise since IPO, to strengthen financials and increase stake in Biocon Biologics.
Achieved major regulatory milestones: US FDA approval for biosimilar insulin Aspart, launches in Canada, and approvals for denosumab in Europe and UK.
Expanded manufacturing capacity with new facilities in India and the US, and received top sustainability ratings.
Board approved unaudited financial results for Q1 FY26, with no auditor qualifications.
Financial highlights
Operating revenue reached ₹3,942 crore, up 15% year-over-year; biosimilars grew 18%, CRDMO up to 17%, and generics 6%.
Core EBITDA was ₹1,003 crore (margin 25%), up 11% year-over-year; reported EBITDA grew 19% to ₹829 crore.
Net profit before exceptional items was ₹31 crore, down 91% year-over-year due to a high base from a one-time gain in Q1 FY25.
Consolidated revenue from operations rose to Rs. 39,419 million, up from Rs. 34,329 million year-over-year.
R&D investments were ₹205 crore (7% of revenues, excluding Syngene); Generics R&D at 10% of segment revenue.
Outlook and guidance
Biosimilars expected to accelerate growth with recent launches and approvals.
CRDMO (Syngene) sees robust demand and is investing to future-proof capabilities.
Generics segment anticipates strong double-digit growth for the full year, driven by new launches in GLP-1s and peptide APIs.
Margins expected to improve in H2 as new capacities ramp up and product launches contribute.
Board and management highlighted ongoing focus on debt reduction, capital allocation, and operational efficiency.
Next Biocon earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage